224 related articles for article (PubMed ID: 16145309)
1. Interleukin-6 and flow-mediated dilatation as markers of increased vascular inflammation in women receiving hormone therapy.
Vitale C; Cornoldi A; Gebara O; Silvestri A; Wajngarten M; Cerquetani E; Fini M; Ramires JA; Rosano GM
Menopause; 2005; 12(5):552-8. PubMed ID: 16145309
[TBL] [Abstract][Full Text] [Related]
2. Increased levels of C-reactive protein after oral hormone replacement therapy may not be related to an increased inflammatory response.
Silvestri A; Gebara O; Vitale C; Wajngarten M; Leonardo F; Ramires JA; Fini M; Mercuro G; Rosano GM
Circulation; 2003 Jul; 107(25):3165-9. PubMed ID: 12796135
[TBL] [Abstract][Full Text] [Related]
3. Effect of lower dosage of oral conjugated equine estrogen on inflammatory markers and endothelial function in healthy postmenopausal women.
Wakatsuki A; Ikenoue N; Shinohara K; Watanabe K; Fukaya T
Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):571-6. PubMed ID: 14699021
[TBL] [Abstract][Full Text] [Related]
4. Effects of tibolone and conventional hormone replacement therapies on arterial and hepatic cholesterol accumulation and on circulating endothelin-1, vascular cell adhesion molecule-1, and E-selectin in surgically menopausal monkeys.
Register TC; Wagner JD; Zhang L; Hall J; Clarkson TB
Menopause; 2002; 9(6):411-21. PubMed ID: 12439100
[TBL] [Abstract][Full Text] [Related]
5. A microarray study on the effect of four hormone therapy regimens on gene transcription in whole blood from healthy postmenopausal women.
Dahm AE; Eilertsen AL; Goeman J; Olstad OK; Ovstebø R; Kierulf P; Mowinckel MC; Skretting G; Sandset PM
Thromb Res; 2012 Jul; 130(1):45-51. PubMed ID: 22217510
[TBL] [Abstract][Full Text] [Related]
6. Comparative effects of continuous combined hormone therapy and tibolone on body composition in postmenopausal women.
Ziaei S; Moaya M; Faghihzadeh S
Climacteric; 2010 Jun; 13(3):249-53. PubMed ID: 19848555
[TBL] [Abstract][Full Text] [Related]
7. The effects of hormone therapy on the markers of inflammation and endothelial function and plasma matrix metalloproteinase-9 level in postmenopausal women: the postmenopausal estrogen progestin intervention (PEPI) trial.
Hu P; Greendale GA; Palla SL; Reboussin BA; Herrington DM; Barrett-Connor E; Reuben DB
Atherosclerosis; 2006 Apr; 185(2):347-52. PubMed ID: 16023653
[TBL] [Abstract][Full Text] [Related]
8. Effect of medroxyprogesterone acetate on vascular inflammatory markers in postmenopausal women receiving estrogen.
Wakatsuki A; Okatani Y; Ikenoue N; Fukaya T
Circulation; 2002 Mar; 105(12):1436-9. PubMed ID: 11914251
[TBL] [Abstract][Full Text] [Related]
9. Modulation by progestogens of the effects of oestrogen on hepatic endocrine function in postmenopausal women.
Nugent AG; Leung KC; Sullivan D; Reutens AT; Ho KK
Clin Endocrinol (Oxf); 2003 Dec; 59(6):690-8. PubMed ID: 14974909
[TBL] [Abstract][Full Text] [Related]
10. Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene.
Christodoulakos G; Lambrinoudaki I; Panoulis C; Sioulas V; Rizos D; Caramalis G; Botsis D; Creatsas G
Maturitas; 2005 Apr; 50(4):321-30. PubMed ID: 15780533
[TBL] [Abstract][Full Text] [Related]
11. Effects of a continuous-combined regimen of low-dose hormone therapy (oestradiol and norethindrone acetate) and tibolone on the quality of life in symptomatic postmenopausal women: a double-blind, randomised study.
Polisseni AF; Andrade AT; Ribeiro LC; Castro IQ; Brandão M; Polisseni F; Guerra Mde O
Maturitas; 2013 Feb; 74(2):172-8. PubMed ID: 23201326
[TBL] [Abstract][Full Text] [Related]
12. The effects of different hormone treatment on endothelial function in healthy postmenopausal women.
Akman L; Duygu H; Akercan F; Ulukus M; Ozerkan F; Akin M
Gynecol Endocrinol; 2013 Sep; 29(9):867-72. PubMed ID: 23875965
[TBL] [Abstract][Full Text] [Related]
13. Effects of hormone therapy on C-reactive protein and IL-6 in postmenopausal women: a review article.
Lakoski SG; Herrington DM
Climacteric; 2005 Dec; 8(4):317-26. PubMed ID: 16390766
[TBL] [Abstract][Full Text] [Related]
14. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
Pluchino N; Genazzani AD; Bernardi F; Casarosa E; Pieri M; Palumbo M; Picciarelli G; Gabbanini M; Luisi M; Genazzani AR
Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide in postmenopausal women taking three different HRT regimens.
Kesim MD; Aydin Y; Erdemir M; Atis A
Maturitas; 2005 Jan; 50(1):52-7. PubMed ID: 15590214
[TBL] [Abstract][Full Text] [Related]
16. Impact of soy supplementation on sex steroids and vascular inflammation markers in postmenopausal women using tibolone: role of equol production capability.
Törmälä R; Appt S; Clarkson TB; Mueck AO; Seeger H; Mikkola TS; Ylikorkala O
Climacteric; 2008 Oct; 11(5):409-15. PubMed ID: 18781486
[TBL] [Abstract][Full Text] [Related]
17. Differential impact of conventional-dose and low-dose postmenopausal hormone therapy, tibolone and raloxifene on C-reactive protein and other inflammatory markers.
Eilertsen AL; Sandvik L; Steinsvik B; Sandset PM
J Thromb Haemost; 2008 Jun; 6(6):928-34. PubMed ID: 18394014
[TBL] [Abstract][Full Text] [Related]
18. Effects of tibolone and continuous combined conjugated equine estrogen/medroxyprogesterone acetate on the endometrium and vaginal bleeding: results of the OPAL study.
Langer RD; Landgren BM; Rymer J; Helmond FA;
Am J Obstet Gynecol; 2006 Nov; 195(5):1320-7. PubMed ID: 16875644
[TBL] [Abstract][Full Text] [Related]
19. Divergent effects of hormone therapy on serum markers of inflammation in postmenopausal women with coronary artery disease on appropriate medical management.
Zanger D; Yang BK; Ardans J; Waclawiw MA; Csako G; Wahl LM; Cannon RO
J Am Coll Cardiol; 2000 Nov; 36(6):1797-802. PubMed ID: 11092646
[TBL] [Abstract][Full Text] [Related]
20. Quality of life and sexuality changes in postmenopausal women receiving tibolone therapy.
Wu MH; Pan HA; Wang ST; Hsu CC; Chang FM; Huang KE
Climacteric; 2001 Dec; 4(4):314-9. PubMed ID: 11770188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
